US2009298095A1PendingUtilityA1
Immortalization of cells including neuronal cells
Est. expiryApr 15, 2025(expired)· nominal 20-yr term from priority
C12N 2510/04G01N 33/5058C12N 9/1276C12N 2799/027G01N 2500/10C12N 5/0619
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The instant invention provides methods for immortalizing cells. The invention further provides immortalized cell lines, e.g., neuronal cell lines, and methods of using these cell lines in screening assays.
Claims
exact text as granted — not AI-modified1 . A method for generating an immortalized human cell comprising:
introducing into a cell a DNA segment encoding an oncogene; selecting for a cell containing the DNA segment; and introducing a hTERT into the selected cell; thereby generating an immortalized cell.
2 . The method of claim 1 , wherein the DNA segment is contained in a plasmid.
3 . The method of claim 1 , wherein hTERT is introduced by a retrovirus.
4 . The method of claim 1 , wherein the cell is a neuronal cell.
5 . The method of claim 4 , wherein the neuronal cell is selected from neuronal cells from the brain, spinal cord, and dorsal root sensory ganglia.
6 . The method of claim 1 , wherein the human cell is a dorsal root ganglia neuron.
7 . The method of claim 6 , wherein the dorsal root ganglion neuron is a nociceptive dorsal root ganglion neuron.
8 . The method of claim 1 , wherein the cell is a glial cell.
9 . The method of claim 8 , wherein the glial cell is an astrocyte, oligodendrocyte or a Schwann cell.
10 . The method of claim 1 , further comprises contacting the immortalized cell with an agent that causes differentiation.
11 . The method of claim 10 , wherein the agent is cyclic AMP or an analog thereof or an agent that increases intracellular cAMP levels.
12 . The method of claim 11 , wherein the agent is forskolin.
13 . A method of producing immortalized neuronal cells comprising:
introducing a DNA segment encoding an oncogene into a neuronal cell; selecting for neuronal cells that contain the DNA segment; introducing hTERT into the selected cells; and selecting for cells that contain hTERT; thereby producing immortalized neuronal cells.
14 . The method of claim 13 , wherein the DNA segment is contained in a plasmid.
15 . The method of claim 13 , wherein the neuronal cells are selected from a group consisting of neuronal cells from the brain, neuronal cells from the spinal cord, dorsal root sensory ganglia, and autonomic ganglia.
16 . The method of claim 13 , wherein the oncogene is selected from the group consisting of Ras, Myc, Raf, and large T-Antigen.
17 - 28 . (canceled)
29 . A method of producing immortalized dorsal root ganglion neuronal cell line comprising:
introducing a plasmid comprising an SV40 large T-antigen into dorsal root ganglion cell; selecting dorsal root ganglion cells that contain the plasmid; introducing hTERT into the selected cells; and selecting for cells that contain hTERT; thereby producing immortalized dorsal root ganglion neuronal line.
30 . The method of claim 29 , wherein hTERT is introduced by a retrovirus.
31 . An immortalized nociceptive dorsal root ganglion neuron.
32 . The immortalized nociceptive dorsal root ganglion neuron of claim 31 , wherein the neuron expresses markers of nociceptive dorsal root ganglion neurons.
33 . The method of claim 24 , wherein the nociceptive dorsal root ganglion neurons express a capsaicin receptor, TRPV1, GDNF-receptor, NGF-receptor, or a sodium channel.
34 . The method of claim 24 , wherein the nociceptive dorsal root ganglion neurons respond to capsaicin by elevating intracellular calcium flux or generate action potentials when polarized.
35 . The immortalized nociceptive dorsal root ganglion neuron of claim 33 , wherein the capsaicin receptor is TRPV1.
36 . The immortalized nociceptive dorsal root ganglion neuron of claim 35 , further comprising an oncogene and hTERT.
37 - 40 . (canceled)
41 . A method of identifying a modulator of pain, comprising:
contacting an immortalized dorsal root ganglion neuronal cell of claim 29 , with a candidate modulator; and determining if the candidate modulator is binds to and/or modulates the dorsal root ganglion neuronal cell; thereby identifying a modulator of pain.Join the waitlist — get patent alerts
Track US2009298095A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.